CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

434 hedge funds and large institutions have $3.7B invested in CRISPR Therapeutics in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 129 increasing their positions, 115 reducing their positions, and 50 closing their positions.

Holders
434
Holders Change
+1
Holders Change %
+0.23%
% of All Funds
7.5%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.14%
New
58
Increased
129
Reduced
115
Closed
50
Calls
$223M
Puts
$213M
Net Calls
+$10.5M
Net Calls Change
+$83K

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$146M
2
Macquarie Group
2
Macquarie Group
Australia
$54.8M
3
Capital International Investors
3
Capital International Investors
California
$349M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$140M
5
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$18.9M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$77.6M
2
AIM
2
ARK Investment Management
Florida
$538M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$2.37M
4
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$279M
5
NAMA
5
Nikko Asset Management Americas
New York
$277M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$538M 8,237,122 -1,490,409 -15%
Capital International Investors
2
Capital International Investors
California
$349M 5,342,418 +678,464 +15%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$279M 4,262,736 -321,362 -7%
NAMA
4
Nikko Asset Management Americas
New York
$277M 4,262,736 -321,362 -7%
BlackRock
5
BlackRock
New York
$153M 2,346,584 +194,458 +9%
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$146M 2,241,445 +2,241,445 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$140M 2,146,444 +527,422 +33%
NMC
8
NEA Management Company
Maryland
$104M 1,590,002 – –
State Street
9
State Street
Massachusetts
$102M 1,568,384 -1,476 -0.1%
Bank of America
10
Bank of America
North Carolina
$96.1M 1,470,682 +243,970 +20%
Vanguard Group
11
Vanguard Group
Pennsylvania
$93.8M 1,435,410 +112,269 +8%
Loomis, Sayles & Company
12
Loomis, Sayles & Company
Massachusetts
$81.4M 1,245,199 -151,059 -11%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$77.6M 1,187,462 -1,827,089 -61%
BG
14
Bellevue Group
Switzerland
$60.7M 928,305 +6,300 +0.7%
AC
15
Armistice Capital
New York
$60.4M 924,000 -76,000 -8%
CS
16
Credit Suisse
Switzerland
$54.9M 840,706 -82,965 -9%
Macquarie Group
17
Macquarie Group
Australia
$54.8M 837,435 +747,413 +830%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$50M 764,676 +50,481 +7%
Goldman Sachs
19
Goldman Sachs
New York
$48.7M 745,906 +250,700 +51%
Norges Bank
20
Norges Bank
Norway
$43.6M 666,768 +76,191 +13%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$42.4M 649,060 +209,134 +48%
Charles Schwab
22
Charles Schwab
California
$40.7M 622,118 +273,995 +79%
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$40.1M 612,890 -50,170 -8%
Renaissance Technologies
24
Renaissance Technologies
New York
$38.8M 593,300 +24,600 +4%
Morgan Stanley
25
Morgan Stanley
New York
$38.3M 585,844 +18,386 +3%
1
2 3 4 5